PURPOSE: The aim of this study was to clarify whether cyclooxygenase-2 and
cyclooxygenase-1 is expressed in hyperplastic polyps and serrated adenomas.
METHODS: Forty-nine serrated adenomas and 25 hyperplastic polyps were immu
nostained using anticyclooxygenase-2 and anticyclooxyenase-1 antibodies. Cy
clooxygenase-2 and cyclooxygenase-1 expression was investigated in all spec
imens. RESULTS: Cyclooxygenase-2 was expressed in dysplastic glands in the
majority of serrated adenomas. Thirty-five of 49 (71.4 percent) serrated ad
enomas exhibited moderate to intense cyclooxygenase-2 immunoreactivity, and
8 of 25 hyperplastic polyps (32 percent) showed weak to moderate cyclooxyg
enase-2 immunoreactivity. Cyclooxygenase-1 immunoreactivity was very weak i
n all the hyperplastic polyps and serrated adenomas. CONCLUSIONS: These res
ults suggest that cyclooxygenase-2 is overexpressed in serrated adenoma of
the colorectum. Cyclooxygenase-2 inhibitors will reduce the incidence of se
rrated adenomas.